Glucarpidase following high-dose methotrexate: update on development.
about
Resumption of high-dose methotrexate after acute kidney injury and glucarpidase use in pediatric oncology patients.High dose methotrexate and extended hours high-flux hemodialysis for the treatment of primary central nervous system lymphoma in a patient with end stage renal disease.Comparable efficacy with varying dosages of glucarpidase in pediatric oncology patients.Efficacy of glucarpidase (carboxypeptidase g2) in patients with acute kidney injury after high-dose methotrexate therapy.Levoleucovorin as replacement for leucovorin in cancer treatment.
P2860
Glucarpidase following high-dose methotrexate: update on development.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Glucarpidase following high-dose methotrexate: update on development.
@en
Glucarpidase following high-dose methotrexate: update on development.
@nl
type
label
Glucarpidase following high-dose methotrexate: update on development.
@en
Glucarpidase following high-dose methotrexate: update on development.
@nl
prefLabel
Glucarpidase following high-dose methotrexate: update on development.
@en
Glucarpidase following high-dose methotrexate: update on development.
@nl
P2860
P1476
Glucarpidase following high-dose methotrexate: update on development.
@en
P2093
Daniel M Patterson
P2860
P304
P356
10.1517/14712590903468677
P407
P577
2010-01-01T00:00:00Z